The cardiac marker myoglobin has been established as a useful tool in the diagnosis of acute myocardial infarction (AMI). Cardiac Myoglobin is a very useful tool in the determination of the source of chest pain. Cell injury from AMI has been shown to result in a level of blood myoglobin above the upper limit of normal in approximately 2-3 hours after the onset of chest pain. Maximum concentrations are generally observed after 9-12 hours. The use of this marker is a great aid in the diagnosis of AMI.
Tell Me Fast™ Myoglobin Rapid Test is used for qualitative determination of cardiac myoglobin in human whole blood, serum and plasma as an aid in the diagnosis of myocardial infarction. Tell Me Fast Myoglobin Rapid Test Device employs a solid-phase chromatographic immunoassay technology to qualitatively detect the elevation of Myoglobin in human blood samples.
Troponin I (TnI) is part of the troponin complex which, together with tropomyosin, forms the main component that regulates the Ca+2-sensitive ATP-ase activity of actomyosin in striated muscle (skeletal and cardiac). The troponin complex consists of three subunits, troponin T(TnT), troponin I(TnI), and troponin C (TnC). Each subunit has a distinct function with TnC as the site of Ca+2 binding, TnT the tropomyosin binding, and TnI as the inhibitory subunit. Different isoforms of TnI exist in the skeletal and cardiac muscles (sTnI and cTnI, respectively) with distinct immunologic epitopes that allow the production of cardiac-specific TnI antibodies. The cardiac marker, troponin I has been established as useful tools in the diagnosis of acute myocardial infarction (AMI). Troponin I is found in blood at elevated concentrations approximately 4- 6 hours after the onset of chest pain and peak at 12-24 hours. Troponin I levels remain elevated for up to 14 days. Biocan Tell Me Fast™ Tropinin Test marker is an aid in the diagnosis of AMI after myocardial infarction.
Tell Me Fast Troponin I Rapid Test Device employs a solid-phase chromatographic immunoassay technology to qualitatively detect the elevation of troponin I in human whole blood, serum and plasma as an aid in the diagnosis of myocardial infarction.
The cardiac marker CK-MB has been established as a useful tool in the diagnosis of acute myocardial infarction (AMI). Cardiac CK-MB is a very useful tool in the determination of the source of chest pain. Cell injury from AMI has been shown to result in a level of blood CK-MB above the upper limit of normal in approximately 2-6 hours after the onset of chest pain. Maximum concentrations are generally observed after 9-12 hours. The use of this marker is a great aid in the diagnosis of AMI.
Tell Me Fast CK-MB Rapid Test Device employs a solid-phase chromatographic immunoassay technology to qualitatively detect the elevation of CK-MB in human blood samples.
The cardiac markers CK-MB, myoglobin, and troponin I have been established as useful tools in the diagnosis of acute myocardial infarction (AMI). Since the temporal release patterns of the three markers have significant differences, all three are useful tools in the determination of the source of chest pain. Cell injury from AMI has been shown to result in a level of blood myoglobin above the upper limit of normal in approximately 2-3 hours after the onset of chest pain. Maximum concentrations are generally observed after 9-12 hours. CK-MB and troponin I are found in blood at elevated concentrations approximately 4- 6 hours after the onset of chest pain and peak at 12-24 hours. However, whereas CK-MB levels return to normal values in about 72 hours, troponin I levels remain elevated for up to 14 days1. The use of these three markers is therefore complementary as an aid in the diagnosis of AMI given the different release times and half-lives after myocardial infarction.
The Tell Me Fast™ Cardiac Myoglobin/CK-MB /Troponin I Rapid Test employs a solid-phase chromatographic immunoassay technology to qualitatively detect the elevation of myoglobin, CK-MB and troponin I in human blood samples.
